Conditioned medium of mesenchymal stem cells pretreated with H(2)O(2) promotes intestinal mucosal repair in acute experimental colitis

Mesenchymal stem cells (MSCs) are a new therapeutic strategy for inflammatory bowel disease (IBD), and their efficacy has been widely recognized. However, there are still some challenges in cell therapy, including stable cell passage, laboratory conditions for cell culture, high-cost burden, and poo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Peng, Xie, Xiao-ran, Wu, Hao, Li, Huan, Chi, Jing-shu, Liu, Xiao-ming, Luo, Ju, Tang, Yu, Xu, Can-xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715703/
https://www.ncbi.nlm.nih.gov/pubmed/36456585
http://dx.doi.org/10.1038/s41598-022-24493-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9715703/
https://www.ncbi.nlm.nih.gov/pubmed/36456585
http://dx.doi.org/10.1038/s41598-022-24493-y

Ejemplares similares